Is vitamin D deficiency a new risk factor for cardiovascular disease?

Open Cardiovascular Medicine Journal

Volumn 9, Issue 1, 2015, Pages 40-49

  Mandarino, Natália Ribeiro ^a   Monteiro Júnior, Francisco das Chagas ^a   Salgado, João Victor Leal ^a   Lages, Joyce Santos ^a   Filho, Natalino Salgado ^a  

^a FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

Author keywords

Atherosclerosis; Cardiometabolic risk; Cardiovascular disease; Risk factor; Supplementation; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; APOLIPOPROTEIN B; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CALCIUM; GAMMA INTERFERON; GELATINASE B; GLUCOSE TRANSPORTER 4; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 10; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL AORTA ANEURYSM; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOMETABOLIC RISK; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CONTROLLED CLINICAL TRIAL (TOPIC); HEART EJECTION FRACTION; HEART INFARCTION; HEART VENTRICLE PRESSURE; HUMAN; HYPERTENSION; IMMUNOMODULATION; INSULIN RELEASE; INSULIN SENSITIVITY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC HEART FAILURE; VITAMIN D DEFICIENCY;

EID: 84928882882     PISSN: None     EISSN: 18741924     Source Type: Journal    
DOI: 10.2174/1874192401509010040     Document Type: Article

References (65)

1. Yusuf S, Reddy S, Ounpuu S, Anad S. Global burden of cardiovascular disease: Part I: General considerations, the epidemiologic transition, Risk factors, and impact of urbanization. Circulation 2001; 104: 2746-53.
2. Reis JP, von Mühlen D, Michos ED, et al. Serum vitamin D, parathyroid hormone levels and carotid atherosclerosis. Atherosclerosis 2009; 207(2): 585-90.
3. Marques CDL, Dantas AT, Fragoso TS, Duarte ALBP. A importância dos níveis de vitamina D nas doenças autoimunes. Rev Bras Reumatol 2010; 50(1): 67-80.
4. Pike JW, Zella LA, Meyer MB, Fretz JA, Kim S. Molecular actions of 1,25-dihydroxyvitamin D3 on genes involved in calcium homeostasis. J Bone Miner Res 2007; 22(Suppl 2): V16-9.
5. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008; 29(6): 726-76.
6. Dini C, Bianchi A. The potential role of vitamin D for prevention and treatment of tuberculosis and infectious diseases. Ann Ist Super Sanità 2012; 48(3): 319-27.
7. Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010; 95: 471-8.
8. Arabi A, El Rassi R, El-Hajj Fuleihan G. Hypovita38minosis D in developing countries-prevalence, risk factors and outcomes. Nat Rev Endocrinol 2010; 6(10): 550-61.
9. Bonakdaran S, Varasteh AR. Correlation between serum 25 hydroxy vitamin D3 and laboratory risk markers of cardiovascular diseases in type 2 diabetic patients. Saudi Med J 2009; 30(4): 509-14.
10. Joergensen C, Hovind P, Schmedes A, Parving HH, Rossing P. Vitamin D levels, microvascular complications, and mortality in type 1 diabetes. Diab Care 2011; 34(5): 1081-5.
11. Amer M, Qayyum R. Relation between serum 25-hydroxyvitamin D and C-reactive protein in symptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). Am J Cardiol 2012; 109(2): 226-30.
12. Syal SK, Kapoor A, Bhatia E, et al. Vitamin D deficiency, coronary artery disease, and Endothelial Dysfunction: Observations from a coronary angiographic study in Indian patients. J Invasive Cardiol 2012; 24(8): 385-9.
13. Tarcin O, Yavuz DG, Ozben B, et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 2009; 94(10): 4023-30.
14. Liu JX, Xiang J, Bu RF, Wu WJ, Shen H, Wang XJ. Serum 25-hydroxyvitamin D concentration is negatively related to carotid artery intima-media thickness in type 2 diabetic patients. Zhonghua Xin Xue Guan Bing Za Zhi 2012; 40(2): 115-9.
15. Targher G, Bertolini L, Padovani R, et al. Serum 25-hydroxivitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol 2006; 65(5): 593-7.
16. Yadav AK, Banerjee D, Lal A, Jha V. Vitamin D deficiency, CD4+CD28null cells and accelerated atherosclerosis in chronic kidney disease. Nephrology (Carlton) 2012; 17(6): 575-81.
17. Zang L, Fu P, Huang YQ, et al. Vitamin D deficiency and carotid artery intima-media thickness and coronary calcification in patients with diabetic nephropathy. Sichuan Da Xue Xue Bao Yi Xue Ban 2012; 43(3): 420-4.
18. Ross AC, Judd S, Kumari M, et al. Vitamin D is linked to carotid intima-media thickness and immune reconstitutionin HIV-positive individuals. Antivir Ther 2011; 16(4): 555-63.
19. Ginde AA, Scragg R, Schwartz RS, Camargo CA, Jr. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 2009; 57(9): 1595-603.
20. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117(4): 503-11.
21. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: A prospective study Arch Intern Med 2008; 168: 1174-80.
22. Ng LL, Sandhu JK, Squire IB, Davies JE, Jones DJ. Vitamin D and prognosis in acute myocardial infarction. Int J Cardiol 2013; 168(3): 2341-6.
23. Pilz S, Dobnig H, Fischer JE, et al. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 2008; 39(9): 2611-13.
24. Brøndum-Jacobsen P, Nordestgaard BG, Schnohr P, Benn M. 25-hydroxyvitamin D and symptomatic ischemic stroke: An original study and meta-analysis. Ann Neurol 2013; 73(1): 38-47.
25. Ameri P, Ronco D, Casu M, et al. High prevalence of vitamin D deficiency and its association with left ventricular dilation: An echocardiography study in elderly patients with chronic heart failure. Nutr Metab Cardiovasc Dis 2010; 20(9): 633-40.
26. Melamed ML, Muntner P, Michos ED, et al. Serum 25-hydroxy vitamin D levels and the prevalence of peripheral arterial disease: Results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol 2008; 28: 1179-85.
27. Wong YY, Flicker L, Yeap BB, McCaul KA, Hankey GJ, Norman PE. Is hypovitaminosis D associated with abdominal aortic aneurysm, and is there a dose-response relationship? Eur J Vasc Endovasc Surg 2013; 45(6): 657-64.
28. Ullah MI, Uwaifo GI, Nicholas WC, Koch CA. Does vitamin d deficiency cause hypertension? Current evidence from clinical studies and potential mechanisms. Int J Endocrinol 2010; 2010: 579-640.
29. Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49(5): 1063-9.
30. Lu L, Yu Z, Pan A, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 2009; 32(7): 1278-83.
31. Miñambres I, Sánchez-Hernández J, Sánchez-Quesada JL, Rodríguez J, de Leiva A, Pére A. The association of hypovitaminosis d with the metabolic syndrome is independent of the degree of obesity. ISRN Endocrinol 2012; 2012: 691803.
32. Pacifico L, Anania C, Osborn JF, et al. Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescentes. Eur J Endocrinol 2011; 165: 603-11.
33. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the 3rd national health and nutrition examination survey. Diabetes Care 2004; 27(12): 2813-8.
34. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab 2007; 92(9): 3517-22.
35. Wang L, Song Y, Manson JE, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: A meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 2012; 5(6): 819-29.
36. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: A negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004; 89-90(1-5): 387-92.
37. Baynes KC, Boucher BJ, Feskens EJ, Kromhout D. Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 1997; 40(3): 344-7.
38. Liu E, Meigs JB, Pittas AG, et al. Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 2009; 139(2): 329-34.
39. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007; 92(6): 2017-29.
40. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79(5): 820-5.
41. Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980; 209(4458): 823-5.
42. The EURODIAB Substudy 2 Study Group. Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. Diabetologia 1999; 42: 51-4.
43. Resnick LM. Calcium metabolism in hypertension and allied metabolic disorders. Diabetes Care 1991; 14(6): 505-20.
44. Wakasugi M, Noguchi T, Inoue M, et al. Vitamin D3 stimulates the production of prostacyclin by vascular smooth muscle cells. Prostaglandins 1991; 42: 127-36.
45. Zittermann A, Koerfer R. Protective and toxic effects of vitamin D on vascular calcification: Clinical implications. Mol Aspects Med 2008; 29(6): 423-32.
46. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001; 167(9): 4974-80.
47. Staeva-Vieira TP, Freedman LP. 1,25-dihydroxyvitamin D3 inhibits IFN gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J Immunol 2002; 168(3): 1181-9.
48. Zittermann A, Koerfer R. Vitamin D in the prevention and treatment of coronary heart disease. Curr Opin Clin Nutr Metab Care 2008; 11(6): 752-7.
49. Hsia J, Heiss G, Ren H, et al. Women’s Health Initiative Investigators. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007; 115: 846-54.
50. Wood AD, Secombes KR, Thies F, et al. Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab 2012; 97(10): 3557-68.
51. Gannagé-Yared MH, Azoury M, Mansour I, Baddoura R, Halaby G, Naaman R. Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy postmenopausal women. J Endocrinol Invest 2003; 26: 748-53.
52. Gepner AD, Ramamurthy R, Krueger DC, Korcarz CE, Binkley N, Stein JH. A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS ONE 2012; 7(5): e36617.
53. Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C: Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001; 86: 1633-37.
54. Forman JP, Scott JB, Ng K, et al. Effect of vitamin D supplementation on blood pressure in blacks. Hypertension 2013; 61(4): 779-85.
55. Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic {beta} cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: The calcium and vitamin d for diabetes mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011; 94: 486-94.
56. Witham MD, Dove FJ, Sugden JA, Doney AS, Struthers AD. The effect of vitamin D replacement on markers of vascular health in stroke patients - a randomised controlled trial. Nutr Metab Cardiovasc Dis 2012; 22(10): 864-70.
57. Yiu YF, Yiu KH, Siu CW, et al. Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 2013; 227(1): 140-6.
58. Zittermann A, Frisch S, Berthold HK, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009; 89: 1321-7.
59. Harris RA, Pedersen-White J, Guo DH, et al. Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults. Am J Hypertens 2011; 24(5): 557-62.
60. Witham MD, Dove FJ, Sugden JA, Doney AS, Struthers AD. The effect of vitamin D replacement on markers of vascular health in stroke patients - a randomised controlled trial. Nutr Metab Cardiovasc Dis 2012; 22(10): 864-70.
61. Witham MD, Crighton LJ, Gillespie ND, Struthers AD, McMurdo ME. The effects of vitamin D supplementation on physical function and quality of life in older heart failure patients: A randomised controlled trial. Circ Heart Fail 2010; 3: 195-201.
62. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: A double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006; 83: 754-9.
63. Amin A, Minaee S, Chitsazan M, Naderi N, Taghavi S, Ardeshiri M. Can vitamin D supplementation improve the severity of congestive heart failure? Congest Heart Fail 2013; 19(4): E22-8.
64. Punthakee Z, Bosch J, Dagenais G, et al. TIDE trial investigators. Design, history and results of the thiazolidinedione intervention with vitamin D Evaluation (TIDE) randomised controlled trial. Diabetologia 2012; 55(1): 36-45.
65. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357(3): 266-81.